Erythromycin Stearate
Who holds supplier records for Erythromycin Stearate? 5 organisations hold a current record for Erythromycin Stearate: an active US FDA Type II Drug Master File. A further 14 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2), United States (1) and Malaysia (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Erythromycin Stearate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/erythromycin-stearate
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Erythromycin Stearate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Abbvie Inc.United States Company GMP cert on recordActive DMF 13372 · latest filing Sept 1998
- Calyx Chemicals & Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 22061 · latest filing Oct 2008
- CENTURY PHARMACEUTICALS LTDActive DMF 34582 · latest filing Mar 2020
- MAHIMA LIFE SCIENCES PRIVATE LTDIndiaActive DMF 27891 · latest filing Dec 2013
- Sm Biomed Sdn. Bhd.Malaysia Company GMP cert on recordActive DMF 32120 · latest filing Nov 2017
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (14)
Organisations whose Type II DMFs for Erythromycin Stearate are no longer active. These show a past filing, not current supply.
Show all 14 historical records
- COMPANHIA INDUSTRIAL PRODUTORA DE ANTIBIOTICOS SARLInactive DMF 14245 · filed Jul 1999
- ERCROS INDUSTRIAL SA FYSEInactive DMF 13467 · filed Sept 1998
- ABBOTT FERMENTATION PRODUCTS DE PUERTO RICO INCInactive DMF 13324 · filed Sept 1998
- POLFAInactive DMF 13393 · filed Sept 1998
- CIBRANInactive DMF 13692 · filed Sept 1998
- United States · Inactive DMF 13530 · filed Sept 1998
- IBIInactive DMF 13381 · filed Sept 1998
- United States · Inactive DMF 13361 · filed Sept 1998
- ANGUS BIOTECH INCInactive DMF 13734 · filed Sept 1998
- ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIVInactive DMF 13510 · filed Sept 1998
- FERMIC SA DE CVInactive DMF 13459 · filed Sept 1998
- DSM CAPUA SPAInactive DMF 13445 · filed Sept 1998
- DIASPA TRADE MARK STRIDES ITALIA SRLInactive DMF 13315 · filed Sept 1998
- ARCHIFAR LABInactive DMF 13478 · filed Sept 1998
Overview
Erythromycin Stearate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200510).
Chemical identity
- IUPAC name
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;octadecanoic acid
- Canonical SMILES
- CCCCCCCCCCCCCCCCCC(=O)O.CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
- InChIKey
- YAVZHCFFUATPRK-YZPBMOCRSA-N
- Synonyms
- Abboticine, Bristamycin, Erypar, Erythrocin 500, Erythrocin acne pack, Erythrocin stearate, Erythromycini stearas, Erythromycin octadecanoate (salt), Erythromycin stearate, Ethril 250, Ethril 500, NSC-756747
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Macrolide; Macrolide Antimicrobial
- Physiologic effect
- Decreased Sebaceous Gland Activity
- Chemical structure
- Macrolides
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Erythromycin Stearate?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Erythromycin Stearate: Abbvie Inc. (United States), Calyx Chemicals & Pharmaceuticals Ltd. (India), CENTURY PHARMACEUTICALS LTD, MAHIMA LIFE SCIENCES PRIVATE LTD (India) and Sm Biomed Sdn. Bhd. (Malaysia). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Erythromycin Stearate Drug Master Files are active?
Abbvie Inc. (DMF 13372), Calyx Chemicals & Pharmaceuticals Ltd. (DMF 22061), CENTURY PHARMACEUTICALS LTD (DMF 34582), MAHIMA LIFE SCIENCES PRIVATE LTD (DMF 27891) and Sm Biomed Sdn. Bhd. (DMF 32120). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Erythromycin Stearate records mean?
14 organisations have only inactive Type II DMFs for Erythromycin Stearate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Erythromycin Stearate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Erythromycin Stearate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.